| INTRODUCTION
Estimates of the burden of seasonal influenza are broadly useful for public health, helping national and local authorities monitor epidemiologic trends, plan and allocate resources, demonstrate the impact of vaccine programs as well as other public health and clinical interventions, and inform the public, clinicians, and policymakers about the importance of influenza and influenza prevention.
Estimates of the burden of seasonal influenza in the United States have evolved over time. First, estimates focused on the number of deaths due to influenza in the 1960s. 1 With better access to hospital records, estimates were expanded to include influenza-related hospitalizations. 2, 3 During the 2009 H1N1 pandemic, there was a need to describe the burden of less severe outcomes, which further expanded the burden estimation to include outpatient medical visits and illness in the community. 4 Changes were also made to the methods used to generate estimate of influenza burden. Statistical models were initially used to estimate excess deaths and hospitalizations, those that occur above what is predicted based on historical trends. 1, 5, 6 During the 2009 H1N1 pandemic, there was a move toward using a multiplier that could extrapolate rates of hospitalization to rates of less severe disease.
Historically, new estimates of influenza-related mortality or hospitalization over multiple influenza seasons were published periodically, as new data became available. [5] [6] [7] However, a hallmark of influenza is 
| GENERATING ANNUAL ESTIMATES OF INFLUENZA BURDEN
Data from the 2010-2011 through 2015-2016 influenza seasons (October through April) have been used on an annual basis to estimate the burden of seasonal influenza and the disease burden averted by influenza vaccination in the United States. [8] [9] [10] [11] [12] [13] The methods have previously been described in detail (Fig. S1 ). 7, 9, [11] [12] [13] [14] Briefly, rates of hospitalization with laboratory-confirmed influenza were obtained from the Influenza Hospitalization Surveillance
Network (FluSurv-NET), a population-based surveillance conducted in 14 geographically distributed states. 15 Hospitalization rates were generated by age group (0-4, 5-17, 18-49, 50-64, and ≥65 years). Rates were adjusted for influenza testing practices and test sensitivity and then applied to the US population to obtain estimates of the number of influenza-associated hospitalizations that occurred each season.
Estimates of excess deaths related to influenza were based on a statistical model of the weekly number of deaths obtained from the National Center for Health Statistics. 16 The model accounts for seasonal trends in mortality and weekly circulation of influenza and respiratory syncytial virus, obtained from national virologic surveillance. 16, 17 The model was fitted using Markov chain Monte Carlo methods, yield- Estimates of the numbers of influenza-associated illnesses, outpatient medical visits, hospitalizations, and deaths prevented by influenza vaccination were derived from burden estimates, influenza vaccination coverage, and vaccine effectiveness, as previously described. 9 Briefly, estimates of monthly influenza vaccine coverage by age group Estimates of the number of illnesses, outpatient medical visits, hospitalizations, and respiratory and circulatory deaths related to seasonal influenza in the United States and the number of illnesses, medical visits, hospitalizations, and deaths related to influenza that were prevented by influenza vaccination are updated annually and published online. 
| ESTIMATED INFLUENZA-ASSOCIATED DISEASE BURDEN PREVENTED THROUGH INFLUENZA VACCINATION
Given the estimates of seasonal incidence of influenza, the associated burden of severe disease, and estimates of influenza vaccine effectiveness and coverage in the United States, we estimate that influenza vaccination has prevented between 1.6 million and 6.7 million illnesses, 790 000-3.1 million outpatient medical visits, 39 000-87 000
hospitalizations, and 3000-10 000 respiratory and circulatory deaths related to influenza each season (Table 2) .
Surveys in the US population suggest that overall vaccination coverage was 42%-47% over the past six influenza seasons, although coverage varies considerably by age. 22 <5 y 900 000-3 800 000 600 000-2 500 000 6000-26 000 60-300 100-700 5-17 y 1 900 000-6 900 000 1 000 000-3 600 000 5000-19 000 50-300 100-600
18-49 y 3 400 000-12 600 000 1 200 000-4 700 000 19 000-71 000 300-2100 900-3600 50-64 y 1 800 000-8 800 000 800 000-3 800 000 20 000-93 000 600-3400 1800-7500 ≥65 y 900 000-5 800 000 500 000-3 300 000 87 000-523 000 3000-17 000 9000-43 000 a Only data on pneumonia and influenza deaths were available in real time during an influenza season; however, pneumonia and influenza deaths are only a subset of the total deaths associated with influenza that occur each year, which may be 2 to 4 times higher when other complications are also considered. Only data on pneumonia and influenza deaths were available in real time during an influenza season; however, pneumonia and influenza deaths are only a subset of the total deaths associated with influenza that occur each year, which may be 2 to 4 times higher when other complications are also considered.
b Data on respiratory and circulatory deaths are available with a three-year lag; therefore, estimates on averted respiratory and circulatory deaths are only available through 2013-2014 influenza season at this time.
c
The estimated fraction of influenza-associated hospitalizations prevented by vaccination was estimated by dividing the estimated number of averted hospitalizations by the estimated number of observed hospitalizations in a given season. Because the estimated number of illnesses in the community and outpatient medical visits is proportional to the estimated hospitalizations, the estimated fraction of community illnesses and outpatient medical visits prevented by vaccination is identical to the fraction of hospitalizations prevented by vaccination.
influenza season, overall vaccination coverage was 46% and we estimate that vaccination prevented more than 5 million illnesses and In addition to being reported annually, CDC estimates of influenza disease burden were expanded to include outpatient medical visits and symptomatic community illness. Estimates focused on influenza-related mortality and hospitalizations reinforce the potentially serious nature of influenza, but are a small fraction of the total burden of influenza and can be biased, as they are highly influenced by patterns and policies for hospital admission, influenza testing, and reporting. 11 On the other hand, estimates of the number of symptomatic community illnesses, for which medical care is not sought but may still result in missed school or work, and outpatient medical visits due to influenza underscore the frequency of influenza illness and its widespread societal impact. We estimate that for every influenza-related hospitalization, between 11 and 365 more non-hospitalized cases occur in the community, depending on the age group. 4, 8 Generating annual estimates of influenza burden helped CDC recognize gaps in influenza surveillance activities. For example, there were no means to directly estimate medically-attended and community illness during the 2009 pandemic. Instead, these portions of influenza burden were indirectly estimated using the rates of influenza-associated hospitalization and field-validated multipliers of healthcare utilization and case-to-hospitalization ratios from the 2009 H1N1 pandemic. In an effort to fill these gaps, there are now several ongoing efforts and collaborations to gather data that can directly estimate the burden of medically-attended illness related to influenza as well as symptomatic community illness on a routine basis. [25] [26] [27] Not only are these improvements to surveillance helpful during seasonal epidemics, but the creation and optimization of surveillance activities that are routine, robust, and near real time will be helpful when a pandemic occurs. 16, 28 The methods and estimates of seasonal influenza burden are not without limitations. First, influenza vaccination coverage estimates and the multipliers used for estimating outpatient medical visits and symptomatic community illness were derived from survey respondents and are subject to recall bias and non-response bias. Second, 
